1H nuclear magnetic resonance spectroscopy-based metabonomic study in patients with cirrhosis and hepatic encephalopathy

World Journal of Hepatology

Volumn 7, Issue 12, 2015, Pages 1701-1707

  Dabos, Konstantinos John ^a   Parkinson, John Andrew ^b   Sadler, Ian Howard ^c   Plevris, John Nicholas ^a   Hayes, Peter Clive ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Branch chain amino acids; Glutamine; Glycolysis; Ketone bodies

Indexed keywords

EID: 84934295554     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v7.i12.1701     Document Type: Article

References (33)

1. Garcia-Tsao G, Lim JK. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol 2009; 104: 1802-1829 [PMID: 19455106 DOI: 10.1038/ajg. 2009.360].
2. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45: 529-538 [PMID: 16879891 DOI: 10.1016/j.jhep.2006.05.013].
3. Bajaj JS. Review article: the modern management of hepatic encephalopathy. Aliment Pharmacol Ther 2010; 31: 537-547 [PMID: 20002027 DOI: 10.1111/j.1365-2036.2009.04211.x].
4. Butterworth RF, Giguère JF, Michaud J, Lavoie J, Layrargues GP. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol 1987; 6: 1-12 [PMID: 3306479 DOI: 10.1007/BF02833598].
5. Kramer L, Tribl B, Gendo A, Zauner C, Schneider B, Ferenci P, Madl C. Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology 2000; 31: 30-34 [PMID: 10613724 DOI: 10.1002/hep.510310107].
6. Schmidt LE, Tofteng F, Strauss GI, Larsen FS. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy. Scand J Gastroenterol 2004; 39: 974-980 [PMID: 15513337].
7. Plauth M, Egberts EH, Hamster W, Török M, Müller PH, Brand O, Fürst P, Dölle W. Long term treatment of latent portosystemic encephalopathy with branch chain amino acids. A double-blind, placebo-controlled trial. J Hepatol 1993; 17: 308-314 [DOI: 10.1016/S0168-8278(05)80210-7].
8. Jalan R, Seery JP, Taylor-Robinson SD. Review article: pathogenesis and treatment of chronic hepatic encephalopathy. Aliment Pharmacol Ther 1996; 10: 681-697 [PMID: 8899075].
9. Strauss GI, Knudsen GM, Kondrup J, Møller K, Larsen FS. Cerebral metabolism of ammonia and amino acids in patients with fulminant hepatic failure. Gastroenterology 2001; 121: 1109-1119 [PMID: 11677203 DOI: 10.1053/gast.2001.29310].
10. Bak LK, Iversen P, Sørensen M, Keiding S, Vilstrup H, Ott P, Waagepetersen HS, Schousboe A. Metabolic fate of isoleucine in a rat model of hepatic encephalopathy and in cultured neural cells exposed to ammonia. Metab Brain Dis 2009; 24: 135-145 [PMID: 19067142 DOI: 10.1007/s11011-008-9123-4].
11. McCullough AJ, Glamour T. Differences in amino acid kinetics in cirrhosis. Gastroenterology 1993; 104: 1858-1865 [PMID: 8500747].
12. Jacobsen EB, Hamberg O, Quistorff B, Ott P. Reduced mitochondrial adenosine triphosphate synthesis in skeletal muscle in patients with Child-Pugh class B and C cirrhosis. Hepatology 2001; 34: 7-12 [PMID: 11431727 DOI: 10.1053/jhep.2001.25451].
13. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999; 29: 1181-1189 [PMID: 10598751 DOI: 10.1080/004982599238047].
14. Gao H, Lu Q, Liu X, Cong H, Zhao L, Wang H, Lin D. Application of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis. Cancer Sci 2009; 100: 782-785 [PMID: 19469021 DOI: 10.1111/j.1349-7006.2009.01086.x].
15. Xue R, Dong L, Wu H, Liu T, Wang J, Shen X. Gas chromatography/mass spectrometry screening of serum metabolomic biomarkers in hepatitis B virus infected cirrhosis patients. Clin Chem Lab Med 2009; 47: 305-310 [PMID: 19676142 DOI: 10.1515/CCLM.2009.083].
16. Barba I, Chatauret N, García-Dorado D, Córdoba J. A 1H nuclear magnetic resonance-based metabonomic approach for grading hepatic encephalopathy and monitoring the effects of therapeutic hypothermia in rats. Liver Int 2008; 28: 1141-1148 [PMID: 18637065 DOI: 10.1111/j.1478-3231.2008.01801.x].
17. Feng B, Wu SM, Lv S, Liu F, Chen HS, Gao Y, Dong FT, Wei L. A novel scoring system for prognostic prediction in d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure BALB/c mice. BMC Gastroenterol 2009; 9: 99 [PMID: 20040118 DOI: 10.1186/1471-230X-9-99].
18. Lindon JC, Nicholson JK, Everet JR. NMR spectroscopy of biofluids. Ann Reports NMR Spectroscopy 1999; 38: 1-87 [DOI: 10.1016/S0066-4103(08)60035-6].
19. Seglen PO. Autoregulation of glycolysis, respiration, gluconeogenesis, and glycogen synthesis in isolated parenchymal rat liver cells under aerobic and anaerobic conditions. Biochim Biophys Acta 1976; 338: 317-336 [DOI: 10.1016/0304-4165(74)90292-X].
20. de Blaauw I, Deutz NE, Boers W, von Meyenfeldt MF. Hepatic amino acid and protein metabolism in non-anorectic, moderately cachectic tumor-bearing rats. J Hepatol 1997; 26: 396-408 [PMID: 9059963].
21. Jalan R, Wright G, Davies NA, Hodges SJ. L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy. Med Hypotheses 2007; 69: 1064-1069 [PMID: 17467190 DOI: 10.1016/j.mehy.2006.12.061].
22. Davies NA, Wright G, Ytrebø LM, Stadlbauer V, Fuskevåg OM, Zwingmann C, Davies DC, Habtesion A, Hodges SJ, Jalan R. L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats. Hepatology 2009; 50: 155-164 [PMID: 19437490 DOI: 10.1002/hep.22897].
23. Ytrebø LM, Kristiansen RG, Maehre H, Fuskevåg OM, Kalstad T, Revhaug A, Cobos MJ, Jalan R, Rose CF. L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure. Hepatology 2009; 50: 165-174 [PMID: 19554542].
24. Fischer JE, Rosen HM, Ebeid AM, James JH, Keane JM, Soeters PB. The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery 1976; 80: 77-91 [PMID: 818729].
25. Plauth M, Egberts EH, Abele R, Müller PH, Fürst P. Characteristic pattern of free amino acids in plasma and skeletal muscle in stable hepatic cirrhosis. Hepatogastroenterology 1990; 37: 135-139 [PMID: 2312039].
26. Cascino A, Cangiano C, Fiaccadori F, Ghinelli F, Merli M, Pelosi G, Riggio O, Rossi Fanelli F, Sacchini D, Stortoni M, Capocaccia L. Plasma and cerebrospinal fluid amino acid patterns in hepatic encephalopathy. Dig Dis Sci 1982; 27: 828-832 [PMID: 7105954 DOI: 10.1007/BF01391377].
27. Zwingmann C, Butterworth R. An update on the role of brain glutamine synthesis and its relation to cell-specific energy metabolism in the hyperammonemic brain: further studies using NMR spectroscopy. Neurochem Int 2005; 47: 19-30 [PMID: 15916833 DOI: 10.1016/j.neuint.2005.04.003].
28. Tessari P, Biolo G, Inchiostro S, Orlando R, Vettore M, Sergi G. Leucine and phenylalanine kinetics in compensated liver cirrhosis: effects of insulin. Gastroenterology 1993; 104: 1712-1721 [PMID: 8500731].
29. Holmin T, Agardh CD, Alinder G, Herlin P, Hultberg B. The influence of total hepatectomy on cerebral energy state, ammoniarelated amino acids of the brain and plasma amino acids in the rat. Eur J Clin Invest 1983; 13: 215-220 [PMID: 6135613 DOI: 10.1111/j.1365-2362.1983.tb00090.x].
30. Swain MS, Bergeron M, Audet R, Blei AT, Butterworth RF. Monitoring of neurotransmitter amino acids by means of an indwelling cisterna magna catheter: a comparison of two rodent models of fulminant liver failure. Hepatology 1992; 16: 1028-1035 [PMID: 1356903 DOI: 10.1002/hep.1840160428].
31. Weissenborn K, Ahl B, Fischer-Wasels D, van den Hoff J, Hecker H, Burchert W, Köstler H. Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy. Gut 2007; 56: 1736-1742 [PMID: 17660226 DOI: 10.1136/gut.2006.110569].
32. Dabos KJ, Newsome PN, Parkinson JA, Mohammed HH, Sadler IH, Plevris JN, Hayes PC. Biochemical prognostic markers of outcome in non-paracetamol-induced fulminant hepatic failure. Transplantation 2004; 77: 200-205 [PMID: 14742981 DOI: 10.1097/01.TP.0000100466.22441.37].
33. Dabos KJ, Newsome PN, Parkinson JA, Davidson JS, Sadler IH, Plevris JN, Hayes PC. A biochemical prognostic model of outcome in paracetamol-induced acute liver injury. Transplantation 2005; 80: 1712-1717 [PMID: 16378066 DOI: 10.1097/01.tp.0000187879.51616. e0].